Nearly 30 researchers and early-stage startups have been selected for two TMC accelerator programs focusing on health technology and cancer therapeutics.
Nearly 30 researchers and early-stage startups have been selected for two TMC accelerator programs focusing on health technology and cancer therapeutics.